GNAO1 and Encephalopathy: We show that, unlike other previously characterized encephalopathy variants, mutations in the Gln52 result in a loss of basic biochemical and cellular activities of the Gα-subunits, providing a novel basis for the molecular etiology of the GNAO1- and GNAI1-related pediatric encephalopathies.